Faculty

Gynecologic Oncology Faculty at University Hospitals

The gynecologic oncology faculty comprises four board-certified, diversely trained, skilled and committed gynecologic oncologists with a proven track record of excellence in patient care, education and research.

  • Steven Waggoner, MD was appointed Chief of the Division of Gynecologic Oncology in 2001. Dr. Waggoner pursued his fellowship training at Georgetown University in Washington, D.C. He was recruited from University of Chicago in 2002 to become Chief, Section of Gynecologic Oncology, University Hospitals of Cleveland, UH MacDonald Women’s Hospital, Case Western Reserve University and in 2004 became Vice-Chairman, Department of Obstetrics and Gynecology, University Hospitals Cleveland Medical Center. He is also the Medical Director of the inpatient Women's Oncology Unit at UH Seidman Cancer Center. Dr. Waggoner is very active nationally in clinical research through the Gynecologic Oncology Group, and also within the Case Comprehensive Cancer Center.
  • Kristine Zanotti, MD is an Associate Professor in the Division of Gynecologic Oncology and also serves as the Gynecologic Oncology Fellowship Program Director. Dr. Zanotti pursued her fellowship in Gynecologic Oncology at the Cleveland Clinic, Cleveland, Ohio in 2000, ultimately joining the division in 2004. She is Director of the Robotic Surgery Program at UH Medical Center and also Director of Surgical Education in the Department of Obstetrics and Gynecology. Dr. Zanotti also has a strong focus in resident and fellow education and holds numerous positions and honors nationally and within the institution related to this focus.

Additional Teaching Clinical Faculty

In addition to the Gynecologic Oncology faculty, other faculty within the institution plays a key role in fellow education:

  • Rodney Ellis, MD is board certified in Radiation Oncology and is the Director of Gynecologic and Pediatric Radiation Oncology at the Case Comprehensive Cancer Center. He is an active clinical investigator and will serve as a potential collaborator for fellow research.
  • Raymond Redline, MD is a Professor of Pathology and fellowship-trained in Gynecologic Pathology. He is an active participant in our weekly Tumor Board conference and will work with the gynecologic oncology fellow on the GO1 rotation reviewing cases and preparing for the Tumor Board conference. Dr. Redline is an active clinical investigator and will serve as a potential collaborator for fellow research.
  • Lee Ponsky, MD is board-certified in Urologic Surgery and is Chief of the Division of Urologic Oncology specializing in urologic oncology. He will serve as the director of the urologic surgery fellowship rotation and will serve as one of many possible clinical mentors for that rotation.
  • Heather McFarland, MD is an Assistant Professor in Critical Care Anesthesiology and will serve as preceptor for the SICU rotation outlined in the proposal. She will also be one of the many potential clinical mentors during their SICU rotation.

Potential Research Mentors

For their research experience, fellows may select from a variety of potential research mentors within UH Cleveland Medical Center, UH Seidman Cancer Center and the co-located Case Western Reserve University School of Medicine to complete their required research project. The following are a list of collaborators and potential research mentors in the areas of translational, clinical, epidemiologic, and public health:

  • Analisa Difeo, PhD is a translational research scientist and Director of the Gynecologic Oncology Translational Research Program. Dr. DiFeo manages a dedicated gynecologic tumor biobank and computer-integrated gynecologic cancer patient database. Her research program includes the investigation of genetic mechanisms associated with ovarian cancer development, progression and chemotherapy response and resistance. More specifically, her lab is devoted to identifying and accelerating the development of new diagnostic and prognostic markers, new cancer prevention and treatment strategies, and to identification of new targets for pharmaceutical interventions. Fellows will interview with Dr. DiFeo within the first month of their fellowship to consider her laboratory and mentorship for their research year.
  • Neal Rote, PhD is a Professor of Reproductive Biology and Pathology and is also Vice Chair for Academic Affairs and Director, Division of Research, Department of Obstetrics and Gynecology. He will serve a critical mentoring role for the gynecologic oncology fellows as a member of each fellow’s Individual Development Plan (IDP) Committee, as a mentor for grant writing, and as a potential mentor within the OB/GYN department for research in the basic sciences. Fellows will interview with Dr. Rote within the first month of their fellowship to consider his laboratory and mentorship for their research year. His relevant research interests relate to the immunological targeting of tumor vasculature, the process of cellular invasion, intercellular fusion, expression and role of endogenous retroviral elements, and sensitivity and resistance to apoptosis. Dr. Rote has extensive experience mentoring both clinical and basic science trainees who have ultimately continued on to productive careers in an academic setting.
  • Siran Koroukian, PhD is an Associate Professor in the Division of Medical Sciences, Department of Epidemiology and Biostatistics. She is leader of the Population and Health Outcomes Research Core, Clinical & Translational Science Collaborative, School of Medicine, Case Western Reserve University, and holds many honors related to teaching and mentoring.
  • Jill Barnholtz-Sloan, PhD is an Associate Professor in the Division of Medical Sciences, Department of Epidemiology and Biostatistics, & Center for Proteomics and Bioinformatics. She is a multidisciplinary-trained epidemiologic and translational research investigator and is the PI on numerous multi-center studies that analyze the genetic/molecular epidemiology of complex diseases.
  • Cheryl L. Thompson, PhD is an Assistant Professor in the Department of Family Medicine. Her primary research interests are in the identification of genetic and molecular factors influencing risk of cancer and factors associated with prognosis and treatment outcomes. Her research focuses on breast, lung, and ovarian cancers, as well as the role of microRNAs in cancer detection, risk and prognosis. Current projects include the identification of inherited genetic variation influencing susceptibility to cancer, and plasma microRNA expression in breast cancer detection and prognosis, as well as lung cancer detection.